Recalcitrant Acneiform Eruption Revealing Behçet’s Disease: A Case with Late but Successful Response to Adalimumab

Detalhes bibliográficos
Autor(a) principal: Vide, Júlia
Data de Publicação: 2018
Outros Autores: Lopes, Sofia, Magina, Sofia, Azevedo, Filomena
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.29021/spdv.75.4.759
Resumo: Behçet's disease is a systemic vasculitis with a chronic-relapsing course, which can lead to significant morbidity and mortality. From the often-compelling challenge of making a prompt diagnosis comes the difficulty in its treatment. We report the case of a patient with an acneiform skin eruption revealing Behçet's disease that was refractory to conventional therapy and later completely responded to adalimumab. Although randomized controlled clinical trials are lacking in the literature, there is already significant evidence supporting anti-TNF agents as a major therapeutic advance in Behçet's disease, particularly in cases that are severe, refractory or intolerant to classical immunosuppression.
id RCAP_d2fac6faec3b869b3102bc1d3e6ca797
oai_identifier_str oai:ojs.revista.spdv.com.pt:article/759
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Recalcitrant Acneiform Eruption Revealing Behçet’s Disease: A Case with Late but Successful Response to AdalimumabErupção Acneiforme Refratária Reveladora de Doença de Behçet: A Propósito de um Caso Clínico com Resposta Tardia mas Eficaz ao AdalimumabAcneiform EruptionsAdalimumabTumor Necrosis Factor-alpha/antagonists & inhibitorsBehcet SyndromeAdalimumabErupções AcneiformesFactor de Necrose Tumoral alfa /antagonistas & inibidoresSíndrome de BehçetBehçet's disease is a systemic vasculitis with a chronic-relapsing course, which can lead to significant morbidity and mortality. From the often-compelling challenge of making a prompt diagnosis comes the difficulty in its treatment. We report the case of a patient with an acneiform skin eruption revealing Behçet's disease that was refractory to conventional therapy and later completely responded to adalimumab. Although randomized controlled clinical trials are lacking in the literature, there is already significant evidence supporting anti-TNF agents as a major therapeutic advance in Behçet's disease, particularly in cases that are severe, refractory or intolerant to classical immunosuppression.A doença de Behçet é uma vasculite sistémica crónica e recidivante que pode levar a um aumento significativo da morbilidade e mortalidade. Após superar o desafio em fazer o seu diagnóstico atempado, que muitas vezes se impõe, surge a dificuldade no seu tratamento. Relata-se um caso de um doente que se apresentou com uma erupção acneiforme reveladora de doença de Behçet, refratária à terapia convencional, que respondeu mais tarde e completamente, ao adalimumab. Na literatura científica, embora faltem ensaios clínicos controlados e randomizados, há já evidência significativa que suporta o papel dos agentes anti-TNF como um importante avanço terapêutico na doença de Behçet, particularmente em casos graves, refratários ou intolerantes à imunossupressão clássica.Sociedade Portuguesa de Dermatologia e Venereologia2018-01-26T00:00:00Zjournal articleinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfimage/tiffimage/tiffimage/tiffhttps://doi.org/10.29021/spdv.75.4.759oai:ojs.revista.spdv.com.pt:article/759Journal of the Portuguese Society of Dermatology and Venereology; Vol 75 No 4 (2017): Outubro - Dezembro; 421-424Revista da Sociedade Portuguesa de Dermatologia e Venereologia; v. 75 n. 4 (2017): Outubro - Dezembro; 421-4242182-24092182-2395reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttps://revista.spdv.com.pt/index.php/spdv/article/view/759https://doi.org/10.29021/spdv.75.4.759https://revista.spdv.com.pt/index.php/spdv/article/view/759/535https://revista.spdv.com.pt/index.php/spdv/article/view/759/724https://revista.spdv.com.pt/index.php/spdv/article/view/759/725https://revista.spdv.com.pt/index.php/spdv/article/view/759/726Vide, JúliaLopes, SofiaMagina, SofiaAzevedo, Filomenainfo:eu-repo/semantics/openAccess2022-10-06T12:35:02Zoai:ojs.revista.spdv.com.pt:article/759Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:11:01.951436Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Recalcitrant Acneiform Eruption Revealing Behçet’s Disease: A Case with Late but Successful Response to Adalimumab
Erupção Acneiforme Refratária Reveladora de Doença de Behçet: A Propósito de um Caso Clínico com Resposta Tardia mas Eficaz ao Adalimumab
title Recalcitrant Acneiform Eruption Revealing Behçet’s Disease: A Case with Late but Successful Response to Adalimumab
spellingShingle Recalcitrant Acneiform Eruption Revealing Behçet’s Disease: A Case with Late but Successful Response to Adalimumab
Vide, Júlia
Acneiform Eruptions
Adalimumab
Tumor Necrosis Factor-alpha/antagonists & inhibitors
Behcet Syndrome
Adalimumab
Erupções Acneiformes
Factor de Necrose Tumoral alfa /antagonistas & inibidores
Síndrome de Behçet
title_short Recalcitrant Acneiform Eruption Revealing Behçet’s Disease: A Case with Late but Successful Response to Adalimumab
title_full Recalcitrant Acneiform Eruption Revealing Behçet’s Disease: A Case with Late but Successful Response to Adalimumab
title_fullStr Recalcitrant Acneiform Eruption Revealing Behçet’s Disease: A Case with Late but Successful Response to Adalimumab
title_full_unstemmed Recalcitrant Acneiform Eruption Revealing Behçet’s Disease: A Case with Late but Successful Response to Adalimumab
title_sort Recalcitrant Acneiform Eruption Revealing Behçet’s Disease: A Case with Late but Successful Response to Adalimumab
author Vide, Júlia
author_facet Vide, Júlia
Lopes, Sofia
Magina, Sofia
Azevedo, Filomena
author_role author
author2 Lopes, Sofia
Magina, Sofia
Azevedo, Filomena
author2_role author
author
author
dc.contributor.author.fl_str_mv Vide, Júlia
Lopes, Sofia
Magina, Sofia
Azevedo, Filomena
dc.subject.por.fl_str_mv Acneiform Eruptions
Adalimumab
Tumor Necrosis Factor-alpha/antagonists & inhibitors
Behcet Syndrome
Adalimumab
Erupções Acneiformes
Factor de Necrose Tumoral alfa /antagonistas & inibidores
Síndrome de Behçet
topic Acneiform Eruptions
Adalimumab
Tumor Necrosis Factor-alpha/antagonists & inhibitors
Behcet Syndrome
Adalimumab
Erupções Acneiformes
Factor de Necrose Tumoral alfa /antagonistas & inibidores
Síndrome de Behçet
description Behçet's disease is a systemic vasculitis with a chronic-relapsing course, which can lead to significant morbidity and mortality. From the often-compelling challenge of making a prompt diagnosis comes the difficulty in its treatment. We report the case of a patient with an acneiform skin eruption revealing Behçet's disease that was refractory to conventional therapy and later completely responded to adalimumab. Although randomized controlled clinical trials are lacking in the literature, there is already significant evidence supporting anti-TNF agents as a major therapeutic advance in Behçet's disease, particularly in cases that are severe, refractory or intolerant to classical immunosuppression.
publishDate 2018
dc.date.none.fl_str_mv 2018-01-26T00:00:00Z
dc.type.driver.fl_str_mv journal article
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.29021/spdv.75.4.759
oai:ojs.revista.spdv.com.pt:article/759
url https://doi.org/10.29021/spdv.75.4.759
identifier_str_mv oai:ojs.revista.spdv.com.pt:article/759
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://revista.spdv.com.pt/index.php/spdv/article/view/759
https://doi.org/10.29021/spdv.75.4.759
https://revista.spdv.com.pt/index.php/spdv/article/view/759/535
https://revista.spdv.com.pt/index.php/spdv/article/view/759/724
https://revista.spdv.com.pt/index.php/spdv/article/view/759/725
https://revista.spdv.com.pt/index.php/spdv/article/view/759/726
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
image/tiff
image/tiff
image/tiff
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Dermatologia e Venereologia
publisher.none.fl_str_mv Sociedade Portuguesa de Dermatologia e Venereologia
dc.source.none.fl_str_mv Journal of the Portuguese Society of Dermatology and Venereology; Vol 75 No 4 (2017): Outubro - Dezembro; 421-424
Revista da Sociedade Portuguesa de Dermatologia e Venereologia; v. 75 n. 4 (2017): Outubro - Dezembro; 421-424
2182-2409
2182-2395
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130566648397824